SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All alpha proteins (14657)
(-)
Fold: Serum albumin-like (99)
(-)
Superfamily: Serum albumin-like (99)
(-)
Family: Serum albumin-like (75)
(-)
Protein domain: Serum albumin (69)
(-)
Human (Homo sapiens) [TaxId: 9606] (69)
1AO6A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1BJ5A:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1BKEA:4-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID
1BM0A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1E78A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1E7AA:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
1E7BA:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-580CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
1E7CA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
1E7EA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)
1E7FA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)
1E7GA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID)
1E7HA:3-196; A:197-388; A:389-583HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)
1E7IA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)
1GNIA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID)
1GNJA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
1H9ZA:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
1HA2A:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) ENANTIOMER OF WARFARIN
1HK1A:5-196; A:197-388; A:389-569HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1HK2A:5-196; A:197-388; A:389-576HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1HK3A:5-196; A:197-388; A:389-575HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1HK4A:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1HK5A:3-196; A:197-388; A:389-584HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1N5UA:2-196; A:197-388; A:389-584X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
1O9XA:4-196; A:197-388; A:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
1TF0A:5-196; A:197-388; A:389-572CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN
1UORA:4-196; A:197-388; A:389-583X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
1YSXA:389-584SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMIN COMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2
2BX8A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
2BXAA:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID (CMPF)
2BXBA:207-378; A:389-582; B:207-378; B:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
2BXEA:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
2BXFA:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
2BXGA:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
2BXHA:5-196; A:197-388; A:389-561; B:5-196; B:197-388; B:389-561HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
2BXLA:197-388; A:389-583; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5-DIIODOSALICYLIC ACID
2BXMA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
2BXNA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
2BXOA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
2BXPA:197-388; A:389-583; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
2ESGC:207-378; C:389-582SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
2I2ZA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN
2I30A:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID
2VUEA:197-388; A:389-579; A:5-196; B:197-388; B:389-575; B:5-196HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z,15E-BILIRUBIN-IX-ALPHA
2XVQA:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
2XVUA:5-196; A:197-388; A:389-579; B:5-196; B:197-388; B:389-571HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
2XW0A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
2XW1A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
2YDFA:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
3A73A:2-196; A:197-388; A:389-584; B:2-196; B:197-388; B:389-584CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
3B9LA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT
3B9MA:197-388; A:389-584; A:3-196HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID
3JRYA:5-196; A:197-388; A:389-579; B:5-196; B:197-388; B:389-579HUMAN SERUM ALBUMIN WITH BOUND SULFATE
3LU6A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
3LU7A:5-196; A:197-388; A:389-582; B:4-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
3LU8A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
3TDLA:3-196; A:197-388; A:389-584STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA
3UIVA:3-196; A:197-388; A:389-584; H:3-196; H:197-388; H:389-584HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
4E99A:5-196; A:197-388; A:389-571HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM
4EMXA:2-196; A:197-388; A:389-582; B:4-196; B:197-388; B:389-582CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
4G03A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
4G04A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
4HGMB:4-196; B:197-388; B:389-492SHARK IGNAR VARIABLE DOMAIN
4K71A:3-196; A:197-388; A:389-585; D:2-196; D:197-388; D:389-585CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
4L8UA:2-196; A:197-388; A:389-584X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN
4L9KA:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
4L9QA:2-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
4LA0A:2-196; A:197-388; A:389-582; B:3-196; B:197-388; B:389-582X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
4LB2A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
4LB9A:2-196; A:197-388; A:389-584X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE
(-)
Protein domain: Vitamin D binding protein (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
1J78A:13-198; A:199-386; A:387-457; B:3-198; B:199-386; B:387-456CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
1J7EA:7-198; A:199-386; A:387-457; B:3-198; B:199-386; B:387-456A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
1KW2A:20-214; A:215-404; A:405-474; B:22-214; B:215-404; B:405-474CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
1KXPD:17-214; D:215-404; D:405-473CRYSTAL STRUCTURE OF HUMAN VITAMIN D-BINDING PROTEIN IN COMPLEX WITH SKELETAL ACTIN
1LOTA:1-198; A:199-386; A:387-457CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D-BINDING PROTEIN
1MA9A:1-198; A:199-386; A:387-458CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN VITAMIN D BINDING PROTEIN AND RABBIT MUSCLE ACTIN